Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Misoprostol for Prevention of Recurrent C. Difficile Infection
NCT03617172Phase 2Terminated
- Sponsor
- Vanderbilt University Medical Center
- Start
- Nov 2018
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of misoprostol in Clostridium difficile infection (CDI), sponsored by Vanderbilt University Medical Center. Started Nov 2018; status: terminated.
02
Drugs
misoprostol
03
Conditions
Clostridium difficile infection (CDI)
Beyond the preview
Go deeper on NCT03617172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03617172.